Totect, Zinecard, Savene (dexrazoxane) is a small molecule pharmaceutical. Dexrazoxane was first approved as Totect on 1995-05-26. It is used to treat breast neoplasms in the USA. It has been approved in Europe to treat extravasation of diagnostic and therapeutic materials.
|Indication||breast neoplasms, extravasation of diagnostic and therapeutic materials|
|Drug Class||Alpha-adrenoceptor antagonists (benzodioxane derivatives)|